| 초록 |
MicroRNA (miRNA), a small fragment RNA (-22 nucleotides) produced from non-coding region of the expressed
RNA, has been demonstrated to be a critical regulator in post-transcriptional regulation for protein expression. However,
identification of collecting duct AQPs-targeting miRNAs and vasopressin-responsive miRNAs in the collecting
ducts have not been demonstrated. To profile miRNAs in the kidney collecting ducts, microarray chip assay (Affymetrix
GeneChip® miRNA 3.0 Array) was done in the tubule suspension of inner medullary collecting duct (IMCD) of rat
kidney in the absence or the presence of dDAVP stimulation (10 nM, 2 h). Fifteen mature miRNAs showing 1.3-fold
changes (p<0.05) were identified as dDAVP-responsive miRNAs. Collecting duct AQPs-targeting miRNAs were selected
by in silico target prediction analysis using TargetScan 6.2. Four miRNAs (miR-32, miR-137, miR-216a, and miR-216b
-5p) for AQP2, one miRNA (miR-194) for AQP3, two miRNAs (miR-148b-3p and miR-152) for AQP4 were predicted.
In silico target prediction analysis using mouse miRNA database also exhibited that miR-137 and miR-32 target AQP2
mRNA. To quantitate the dDAVP-dependent changes of expression of collecting duct AQPs-targeting miRNAs, RTqPCR
analysis was performed. Moreover, prediction analysis to identify target proteins of miRNA involved in the
vasopressin-mediated signaling pathways was done using DIANA-mirPath. The results demonstrated that miR-137
and miR-32 could target mRNAs involved vasopressin-mediated signaling, such as MAPK signaling, calcium signaling,
phosphatidylinositol signaling, and mTOR signaling. Taken together, we identified several potential collecting duct
AQPs-targeting miRNAs and demonstrated the changes of vasopressin-responsive miRNAs expression. Further studies
are undertaken to confirm their specificity to AQP2, AQP3, and AQP4, and to examine as to whether regulation of
miRNAs specific to collecting duct AQPs could be used to treat water balance disorders. |